HIMSS Analytics

himssanalytics.com

HIMSS Analytics is a global healthcare advisor, providing guidance and market intelligence solutions that move the industry forward with insight to enable better health through the use of information and technology. In utilizing maturity models, HIMSS Analytics identifies best practices and outlines a strategic roadmap that leads transformational change. HIMSS Analytics has helped hospitals and clinical practices track and benchmark their EMR adoption and utilization goals since 2005 through the EMR Adoption Model (EMRAM). EMRAM provides a roadmap and guidance along an 8-stage model with comparisons to healthcare organizations in the same country and around the world.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industry Outlook

ANDELYN BIOSCIENCES SELECTS TETRASCIENCE AS A STRATEGIC PARTNER FOR INNOVATION IN THERAPEUTICS DEVELOPMENT AND MANUFACTURING

Andelyn Biosciences | August 26, 2021

news image

TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers. As part of an Andelyn Biosciences initiative to create a Connected Plant that harmonizes data from building and facilities, process and manufacturing, and lab instrument sources, TDP will enable better compliance, easier analysis, faster decisions, and more agile operations. Additio...

Read More

Cell and Gene Therapy, Industrial Impact

LINEAGE ENTERS EXCLUSIVE OPTION AND LICENSE AGREEMENT WITH ETERNA

Lineage Cell Therapeutics, Inc. | February 23, 2023

news image

On February 22, 2023, Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology firm focused on the development of allogeneic cell therapies to restore and replace specific cell types of the human body, announced that it has entered into an exclusive option and license agreement with Eterna Therapeutics Inc. (Eterna) for the development of innovative beta 2 microglobulin (B2M)-deficient induced pluripotent stem cell (iPSC) lines that Lineage will assess for the creation of unique, di...

Read More

Cell and Gene Therapy

SPATIAL BIOLOGY CRO FLAGSHIP BIOSCIENCES ACQUIRES PHARMA SERVICES BUSINESS FROM INTERPACE BIOSCIENCES

Flagship Biosciences, Inc. | September 01, 2022

news image

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions® a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions. This acquisition follows a growth equity investment in Flagship from Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies. The strategic combination of Flagship and IPS creates a full repert...

Read More

MedTech

NOVIR ANNOUNCES THE EVOLUTION OF THEIR BUSINESS TO A MORE COMPREHENSIVE HEALTHCARE SOLUTIONS PROVIDER FOCUSED ON ADVANCING THE PRE-CARE PATHWAY

Businesswire | June 08, 2023

news image

Novir, an emerging biotechnology company, focused on pioneering the pre-care pathway to better health, has announced today the launch of their refreshed brand, dedicated to showcasing the evolution Novir has taken from a COVID-19 testing and vaccination provider to a more comprehensive healthcare solution committed to advancing healthcare from sick-care to pre-care by offering affordable, accessible, and reliable screening solutions to anyone, anywhere, anytime. Since their ince...

Read More
news image

Industry Outlook

ANDELYN BIOSCIENCES SELECTS TETRASCIENCE AS A STRATEGIC PARTNER FOR INNOVATION IN THERAPEUTICS DEVELOPMENT AND MANUFACTURING

Andelyn Biosciences | August 26, 2021

TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers. As part of an Andelyn Biosciences initiative to create a Connected Plant that harmonizes data from building and facilities, process and manufacturing, and lab instrument sources, TDP will enable better compliance, easier analysis, faster decisions, and more agile operations. Additio...

Read More
news image

Cell and Gene Therapy, Industrial Impact

LINEAGE ENTERS EXCLUSIVE OPTION AND LICENSE AGREEMENT WITH ETERNA

Lineage Cell Therapeutics, Inc. | February 23, 2023

On February 22, 2023, Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology firm focused on the development of allogeneic cell therapies to restore and replace specific cell types of the human body, announced that it has entered into an exclusive option and license agreement with Eterna Therapeutics Inc. (Eterna) for the development of innovative beta 2 microglobulin (B2M)-deficient induced pluripotent stem cell (iPSC) lines that Lineage will assess for the creation of unique, di...

Read More
news image

Cell and Gene Therapy

SPATIAL BIOLOGY CRO FLAGSHIP BIOSCIENCES ACQUIRES PHARMA SERVICES BUSINESS FROM INTERPACE BIOSCIENCES

Flagship Biosciences, Inc. | September 01, 2022

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions® a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions. This acquisition follows a growth equity investment in Flagship from Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies. The strategic combination of Flagship and IPS creates a full repert...

Read More
news image

MedTech

NOVIR ANNOUNCES THE EVOLUTION OF THEIR BUSINESS TO A MORE COMPREHENSIVE HEALTHCARE SOLUTIONS PROVIDER FOCUSED ON ADVANCING THE PRE-CARE PATHWAY

Businesswire | June 08, 2023

Novir, an emerging biotechnology company, focused on pioneering the pre-care pathway to better health, has announced today the launch of their refreshed brand, dedicated to showcasing the evolution Novir has taken from a COVID-19 testing and vaccination provider to a more comprehensive healthcare solution committed to advancing healthcare from sick-care to pre-care by offering affordable, accessible, and reliable screening solutions to anyone, anywhere, anytime. Since their ince...

Read More